216 related articles for article (PubMed ID: 6723574)
21. Metabolism of prolactin in mice with a high incidence of mammary tumours: evidence for greater conversion into a non-immunoassayable form.
Sinha YN; Baxter SR
J Endocrinol; 1979 Jun; 81(3):299-314. PubMed ID: 469461
[TBL] [Abstract][Full Text] [Related]
22. Prolactin and the development and progression of early neoplastic mammary gland lesions.
Welsch CW
Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
[TBL] [Abstract][Full Text] [Related]
23. Irradiation and prolactin effects on rat mammary carcinogenesis: intrasplenic pituitary and estrone capsule implants.
Clifton KH; Yasukawa-Barnes J; Tanner MA; Haning RV
J Natl Cancer Inst; 1985 Jul; 75(1):167-75. PubMed ID: 3859689
[TBL] [Abstract][Full Text] [Related]
24. Caloric restriction perturbs the pituitary-ovarian axis and inhibits mouse mammary tumor virus production in a high-spontaneous-mammary-tumor-incidence mouse strain (C3H/SHN).
Koizumi A; Masuda H; Wada Y; Tsukada M; Kawamura K; Kamiyama S; Walford RL
Mech Ageing Dev; 1989 Aug; 49(2):93-104. PubMed ID: 2552231
[TBL] [Abstract][Full Text] [Related]
25. Changes in molecular variants during in vitro transformation and release of prolactin by the pituitary gland of the lactating rat.
Mena F; Hummelt G; Aguayo D; Clapp C; Martínez de la Escalera G; Morales MT
Endocrinology; 1992 Jun; 130(6):3365-77. PubMed ID: 1597148
[TBL] [Abstract][Full Text] [Related]
26. Three growth hormone- and two prolactin-related novel peptides of Mr 13,000-18,000 identified in the anterior pituitary.
Sinha YN; Jacobsen BP
Biochem Biophys Res Commun; 1988 Oct; 156(1):171-9. PubMed ID: 3178830
[TBL] [Abstract][Full Text] [Related]
27. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
Powell BL; Diamond EJ; Koprak S; Hollander VP
Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
[TBL] [Abstract][Full Text] [Related]
28. Isolation and partial characterization of secreted hamster pituitary prolactin.
Colosi P; Markoff E; Levy A; Ogren L; Shine N; Talamantes F
Endocrinology; 1981 Mar; 108(3):850-4. PubMed ID: 7460846
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
Sagar SM; Millard WJ; Martin JB; Murchison SC
Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
[TBL] [Abstract][Full Text] [Related]
30. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.
Bression D; Brandi AM; Pagesy P; Le Dafniet M; Martinet M; Brailly S; Michard M; Peillon F
Endocrinology; 1985 May; 116(5):1905-11. PubMed ID: 3987624
[TBL] [Abstract][Full Text] [Related]
32. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
Parsons JA; Peterson EK; Hartfel MA
Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
[TBL] [Abstract][Full Text] [Related]
33. Acute stimulation of prolactin release by estradiol: mediation by the posterior pituitary.
Murai I; Ben-Jonathan N
Endocrinology; 1990 Jun; 126(6):3179-84. PubMed ID: 2351112
[TBL] [Abstract][Full Text] [Related]
34. Gonadal function in aging rats and its relation to pituitary and mammary pathology.
Goya RG; Lu JK; Meites J
Mech Ageing Dev; 1990 Oct; 56(1):77-88. PubMed ID: 2259256
[TBL] [Abstract][Full Text] [Related]
35. The effects of estradiol on prolactin and growth hormone secretion in cultured pituitary cells from intact and ovariectomized rats.
Komolov IS; Perez-Arce JA; Fedotov VP
Endokrinologie; 1980 Jun; 75(3):278-84. PubMed ID: 7428709
[TBL] [Abstract][Full Text] [Related]
36. Characterization of prolactin-releasing factor in the rat posterior pituitary.
Hyde JF; Ben-Jonathan N
Endocrinology; 1988 Jun; 122(6):2533-9. PubMed ID: 3131118
[TBL] [Abstract][Full Text] [Related]
37. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice.
Hentges ST; Low MJ
Endocrinology; 2002 Dec; 143(12):4536-43. PubMed ID: 12446580
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms.
Clapp C
Endocrinology; 1987 Dec; 121(6):2055-64. PubMed ID: 3315634
[TBL] [Abstract][Full Text] [Related]
39. Cell-specific induction of c-fos expression in the pituitary gland by estrogen.
Allen DL; Mitchner NA; Uveges TE; Nephew KP; Khan S; Ben-Jonathan N
Endocrinology; 1997 May; 138(5):2128-35. PubMed ID: 9112413
[TBL] [Abstract][Full Text] [Related]
40. Prolactin status of hereditary dwarf mice.
Barkley MS; Bartke A; Gross DS; Sinha YN
Endocrinology; 1982 Jun; 110(6):2088-96. PubMed ID: 7075549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
